The Food and Drug Administration is ramping up technology adoption, and prioritizing AI and data strategies to ensure safety of new interventions and medical devices, improve workflows and ultimately deliver on its public health mission. Arunan Skandarajah, an FDA Presidential Innovation Fellow who believes in the power of equitable digital tools, discusses how he is innovating FDA’s regulatory processes to drive greater efficiencies.
HealthCast
Season 2
Episode 30
36m listen
How AI, Data Are Boosting FDA’s Regulatory Processes
A Presidential Innovation Fellow is helping the agency improve workflows and ultimately ensure safety of the drugs and treatments it regulates.
-
Arunan Skandarajah Presidential Innovation Fellow FDA
Related Content
-
NCI Uses Wearables Data to Link Exercise to Cancer Risk
NCI finds a connection between low-intensity exercise and decreased risk of cancer through data collected from wearable technology.
9m listen -
AI Boosts Customer Experience at Federal Contact Centers
Federal contact center leaders at DOL and VA are exploring AI's potential to drive efficiency and boost customer experience.
3m read -
President's FY2026 Budget Request Puts Big Bets on Tech
OMB proposes significant reductions for civilian agencies, but earmarks funds for AI, space exploration and energy.
3m read -
Feds Modernize Services to Improve User Experience
Tech leaders at CMS, USPTO and IRS are leveraging tech and bolstering security to drive new efficiencies and enhance user experience.
5m read
